Skip to content
Article Rich – Lifestyle
Author:
Mira Pharmaceuticals, Inc.
MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
August 6, 2026
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
July 30, 2026